The clinicopathological features included patient age, sex, tumor diameter, morphology, tumor location, lymphatic invasion, vascular invasion, tumor differentiation, carcinoembryonic antigen and carbohydrate antigen 19‐9 levels, number of lymph node dissections, presence of adenoma component, and LNM. This evidence concerns the gene CEACAM5 and neoplasm.